The latest update to the Mirth Connect tool by NextGen revealed a code execution vulnerability (CVE-2023-43208) in software versions pre-dating 4.4.1. According to the National Institute of Standards and Technology (NIST) analysis, the tool, aimed at healthcare, primarily has versions dating back to 2015/16 at risk, specifically those versions on the internet. NextGen recommended an upgrade to the latest software version to combat the vulnerability.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
